Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
MyoKardia, Inc.
Iacopo Olivotto; Artur Oreziak; Roberto Barriales-Villa; Theodore P Abraham; Ahmad Masri; Pablo Garcia-Pavia; Sara Saberi; Neal K Lakdawala; Matthew T Wheeler; Anjali Owens; Milos Kubanek; Wojciech Wojakowski; Morten K Jensen; Juan Gimeno-Blanes; Kia Afshar; Jonathan Myers; Sheila M Hegde; Scott D Solomon; Amy J Sehnert; David Zhang; Wanying Li; Mondira Bhattacharya; Jay M Edelberg; Cynthia Burstein Waldman; Steven J Lester; Andrew Wang; Carolyn Y Ho; Daniel Jacoby; EXPLORER-HCM study investigators